Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Protein protects against heart damage following cancer treatment

Protein protects against heart damage following cancer treatment

Novel nanofluidic device for exosome nanoporation

Novel nanofluidic device for exosome nanoporation

Therapy using artificial metalloenzymes helps reduce tumor growth, finds study

Therapy using artificial metalloenzymes helps reduce tumor growth, finds study

Scientists identify new target to deliver anti-cancer drugs to tumor cells

Scientists identify new target to deliver anti-cancer drugs to tumor cells

Novel DNA-based nanogel for targeted delivery of chemotherapeutics

Novel DNA-based nanogel for targeted delivery of chemotherapeutics

New nanoparticles can destroy drug-resistant cancer cells

New nanoparticles can destroy drug-resistant cancer cells

Study reveals key factor that influences malignant cells to develop into tumor

Study reveals key factor that influences malignant cells to develop into tumor

Novel nano drug candidate kills triple negative breast cancer cells

Novel nano drug candidate kills triple negative breast cancer cells

Study demonstrates the role of p53 gene in cell cycle regulation and apoptosis

Study demonstrates the role of p53 gene in cell cycle regulation and apoptosis

Nanobowl-stabilized liposomes are less leaky than regular liposomes

Nanobowl-stabilized liposomes are less leaky than regular liposomes